Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268

1.

Enteropathogen antibody dynamics and force of infection among children in low-resource settings.

Arnold BF, Martin DL, Juma J, Mkocha H, Ochieng JB, Cooley GM, Omore R, Goodhew EB, Morris JF, Costantini V, Vinjé J, Lammie PJ, Priest JW.

Elife. 2019 Aug 19;8. pii: e45594. doi: 10.7554/eLife.45594.

2.

The public health control of scabies: priorities for research and action.

Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, Enbiale W, Engels D, Hay RJ, Hendrickx D, Hotez PJ, Kaldor JM, Kama M, Mackenzie CD, McCarthy JS, Martin DL, Mengistu B, Maurer T, Negussu N, Romani L, Sokana O, Whitfeld MJ, Fuller LC, Steer AC.

Lancet. 2019 Jul 6;394(10192):81-92. doi: 10.1016/S0140-6736(19)31136-5. Epub 2019 Jun 6. Review.

PMID:
31178154
3.

Optimization of a rapid test for antibodies to the Chlamydia trachomatis antigen Pgp3.

Gwyn S, Mkocha H, Randall JM, Kasubi M, Martin DL.

Diagn Microbiol Infect Dis. 2019 Apr;93(4):293-298. doi: 10.1016/j.diagmicrobio.2018.11.001. Epub 2018 Nov 10.

4.

Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.

Kim JS, Oldenburg CE, Cooley G, Amza A, Kadri B, Nassirou B, Cotter SY, Stoller NE, West SK, Bailey RL, Keenan JD, Gaynor BD, Porco TC, Lietman TM, Martin DL.

PLoS Negl Trop Dis. 2019 Jan 28;13(1):e0007127. doi: 10.1371/journal.pntd.0007127. eCollection 2019 Jan.

5.

The utility of serology for elimination surveillance of trachoma.

Pinsent A, Solomon AW, Bailey RL, Bid R, Cama A, Dean D, Goodhew B, Gwyn SE, Jack KR, Kandel RP, Kama M, Massae P, Macleod C, Mabey DCW, Migchelsen S, Müller A, Sandi F, Sokana O, Taoaba R, Tekeraoi R, Martin DL, White MT.

Nat Commun. 2018 Dec 21;9(1):5444. doi: 10.1038/s41467-018-07852-0.

6.

Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem.

Senyonjo LG, Debrah O, Martin DL, Asante-Poku A, Migchelsen SJ, Gwyn S, deSouza DK, Solomon AW, Agyemang D, Biritwum-Kwadwo N, Marfo B, Bakajika D, Mensah EO, Aboe A, Koroma J, Addy J, Bailey R.

PLoS Negl Trop Dis. 2018 Dec 14;12(12):e0007027. doi: 10.1371/journal.pntd.0007027. eCollection 2018 Dec.

7.

Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.

Wilson N, Goodhew B, Mkocha H, Joseph K, Bandea C, Black C, Igietseme J, Munoz B, West SK, Lammie P, Kasubi M, Martin DL.

Ophthalmic Epidemiol. 2019 Feb;26(1):1-6. doi: 10.1080/09286586.2017.1293693. Epub 2018 Dec 13.

8.

Advancing the public health applications of Chlamydia trachomatis serology.

Woodhall SC, Gorwitz RJ, Migchelsen SJ, Gottlieb SL, Horner PJ, Geisler WM, Winstanley C, Hufnagel K, Waterboer T, Martin DL, Huston WM, Gaydos CA, Deal C, Unemo M, Dunbar JK, Bernstein K.

Lancet Infect Dis. 2018 Dec;18(12):e399-e407. doi: 10.1016/S1473-3099(18)30159-2. Epub 2018 Jul 5. Review.

PMID:
29983342
9.

Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis.

Butcher R, Sokana O, Jack K, Sui L, Russell C, Last A, Martin DL, Burton MJ, Solomon AW, Mabey DCW, Roberts CH.

Wellcome Open Res. 2018 Feb 22;3:14. doi: 10.12688/wellcomeopenres.13423.2. eCollection 2018.

10.

Latent class modeling to compare testing platforms for detection of antibodies against the Chlamydia trachomatis antigen Pgp3.

Wiegand RE, Cooley G, Goodhew B, Banniettis N, Kohlhoff S, Gwyn S, Martin DL.

Sci Rep. 2018 Mar 9;8(1):4232. doi: 10.1038/s41598-018-22708-9.

11.

Prevalence of Chlamydia trachomatis-Specific Antibodies before and after Mass Drug Administration for Trachoma in Community-Wide Surveys of Four Communities in Nepal.

Gwyn SE, Xiang L, Kandel RP, Dean D, Gambhir M, Martin DL.

Am J Trop Med Hyg. 2018 Jan;98(1):216-220. doi: 10.4269/ajtmh.17-0102. Epub 2018 Jan 1.

12.

Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia.

Migchelsen SJ, Sepúlveda N, Martin DL, Cooley G, Gwyn S, Pickering H, Joof H, Makalo P, Bailey R, Burr SE, Mabey DCW, Solomon AW, Roberts CH.

Sci Rep. 2017 Nov 8;7(1):15040. doi: 10.1038/s41598-017-15056-7.

13.

Comparison of Platforms for Testing Antibody Responses against the Chlamydia trachomatis Antigen Pgp3.

Gwyn S, Cooley G, Goodhew B, Kohlhoff S, Banniettis N, Wiegand R, Martin DL.

Am J Trop Med Hyg. 2017 Dec;97(6):1662-1668. doi: 10.4269/ajtmh.17-0292. Epub 2017 Sep 21.

14.

Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati.

Cama A, Müller A, Taoaba R, Butcher RMR, Itibita I, Migchelsen SJ, Kiauea T, Pickering H, Willis R, Roberts CH, Bakhtiari A, Le Mesurier RT, Alexander NDE, Martin DL, Tekeraoi R, Solomon AW; Global Trachoma Mapping Project.

PLoS Negl Trop Dis. 2017 Sep 12;11(9):e0005863. doi: 10.1371/journal.pntd.0005863. eCollection 2017 Sep.

15.

Complex interactions between the subject factors of biological sex and prior histories of binge-drinking and unpredictable stress influence behavioral sensitivity to alcohol and alcohol intake.

Quadir SG, Guzelian E, Palmer MA, Martin DL, Kim J, Szumlinski KK.

Physiol Behav. 2019 May 1;203:100-112. doi: 10.1016/j.physbeh.2017.08.002. Epub 2017 Aug 10.

PMID:
28803118
16.

Methamphetamine-alcohol interactions in murine models of sequential and simultaneous oral drug-taking.

Fultz EK, Martin DL, Hudson CN, Kippin TE, Szumlinski KK.

Drug Alcohol Depend. 2017 Aug 1;177:178-186. doi: 10.1016/j.drugalcdep.2017.03.026. Epub 2017 May 24.

17.

Evaluation of a field test for antibodies against Chlamydia trachomatis during trachoma surveillance in Nepal.

Sun MJ, Zambrano AI, Dize L, Munoz B, Gwyn S, Mishra S, Martin DL, Sharma S, West SK.

Diagn Microbiol Infect Dis. 2017 May;88(1):3-6. doi: 10.1016/j.diagmicrobio.2017.01.004. Epub 2017 Jan 17.

PMID:
28214223
18.

Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies.

Migchelsen SJ, Martin DL, Southisombath K, Turyaguma P, Heggen A, Rubangakene PP, Joof H, Makalo P, Cooley G, Gwyn S, Solomon AW, Holland MJ, Courtright P, Willis R, Alexander ND, Mabey DC, Roberts CH.

PLoS Negl Trop Dis. 2017 Jan 18;11(1):e0005230. doi: 10.1371/journal.pntd.0005230. eCollection 2017 Jan.

19.

Differential diagnosis of a progressive neuromuscular disorder using bioarchaeological and biogeochemical evidence from a bronze age skeleton in the UAE.

Schrenk A, Gregoricka LA, Martin DL, Potts DT.

Int J Paleopathol. 2016 Jun;13:1-10. doi: 10.1016/j.ijpp.2015.12.004. Epub 2016 Jan 14.

PMID:
29539503
20.

Lateral flow-based antibody testing for Chlamydia trachomatis.

Gwyn S, Mitchell A, Dean D, Mkocha H, Handali S, Martin DL.

J Immunol Methods. 2016 Aug;435:27-31. doi: 10.1016/j.jim.2016.05.008. Epub 2016 May 18.

21.

Evaluation of Multiplex-Based Antibody Testing for Use in Large-Scale Surveillance for Yaws: a Comparative Study.

Cooley GM, Mitja O, Goodhew B, Pillay A, Lammie PJ, Castro A, Moses P, Chen C, Ye T, Ballard R, Martin DL.

J Clin Microbiol. 2016 May;54(5):1321-5. doi: 10.1128/JCM.02572-15. Epub 2016 Mar 9.

22.

Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.

Pant BP, Bhatta RC, Chaudhary JS, Awasthi S, Mishra S, Sharma S, Cuddapah PA, Gwyn SE, Stoller NE, Martin DL, Keenan JD, Lietman TM, Gaynor BD.

PLoS Negl Trop Dis. 2016 Feb 12;10(2):e0004462. doi: 10.1371/journal.pntd.0004462. eCollection 2016 Feb.

23.

Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey.

West SK, Munoz B, Weaver J, Mrango Z, Dize L, Gaydos C, Quinn TC, Martin DL.

PLoS Negl Trop Dis. 2016 Jan 15;10(1):e0004352. doi: 10.1371/journal.pntd.0004352. eCollection 2016 Jan.

24.

Serological Measures of Trachoma Transmission Intensity.

Martin DL, Wiegand R, Goodhew B, Lammie P, Black CM, West S, Gaydos CA, Dize L, Mkocha H, Kasubi M, Gambhir M.

Sci Rep. 2015 Dec 21;5:18532. doi: 10.1038/srep18532.

25.

Trachoma and Yaws: Common Ground?

Solomon AW, Marks M, Martin DL, Mikhailov A, Flueckiger RM, Mitjà O, Asiedu K, Jannin J, Engels D, Mabey DC.

PLoS Negl Trop Dis. 2015 Dec 3;9(12):e0004071. doi: 10.1371/journal.pntd.0004071. eCollection 2015 Dec. Review. No abstract available.

26.

Challenges and key research questions for yaws eradication.

Marks M, Mitjà O, Vestergaard LS, Pillay A, Knauf S, Chen CY, Bassat Q, Martin DL, Fegan D, Taleo F, Kool J, Lukehart S, Emerson PM, Solomon AW, Ye T, Ballard RC, Mabey DCW, Asiedu KB.

Lancet Infect Dis. 2015 Oct;15(10):1220-1225. doi: 10.1016/S1473-3099(15)00136-X. Epub 2015 Sep 8. Review.

27.

Potential sexual transmission of Trypanosoma cruzi in mice.

Martin DL, Lowe KR, McNeill T, Thiele EA, Roellig DM, Zajdowicz J, Hunter SA, Brubaker SA.

Acta Trop. 2015 Sep;149:15-8. doi: 10.1016/j.actatropica.2015.05.002. Epub 2015 May 14.

28.

Symbolic bones and interethnic violence in a frontier zone, northwest Mexico, ca. 500-900 C.E.

Nelson BA, Martin DL.

Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9196-201. doi: 10.1073/pnas.1422337112. Epub 2015 May 4.

29.

Ground level air convection produces frost damage patterns in turfgrass.

Ackerson BJ, Beier RA, Martin DL.

Int J Biometeorol. 2015 Nov;59(11):1655-65. doi: 10.1007/s00484-015-0972-3. Epub 2015 Mar 22.

PMID:
25796203
30.

Serology for trachoma surveillance after cessation of mass drug administration.

Martin DL, Bid R, Sandi F, Goodhew EB, Massae PA, Lasway A, Philippin H, Makupa W, Molina S, Holland MJ, Mabey DC, Drakeley C, Lammie PJ, Solomon AW.

PLoS Negl Trop Dis. 2015 Feb 25;9(2):e0003555. doi: 10.1371/journal.pntd.0003555. eCollection 2015 Feb.

31.

Bioarchaeological contributions to the study of violence.

Martin DL, Harrod RP.

Am J Phys Anthropol. 2015 Feb;156 Suppl 59:116-45. doi: 10.1002/ajpa.22662. Epub 2014 Nov 19. Review.

PMID:
25407549
32.

Circulating serum markers and QRS scar score in Chagas cardiomyopathy.

Clark EH, Marks MA, Gilman RH, Fernandez AB, Crawford TC, Samuels AM, Hidron AI, Galdos-Cardenas G, Menacho-Mendez GS, Bozo-Gutierrez RW, Martin DL, Bern C.

Am J Trop Med Hyg. 2015 Jan;92(1):39-44. doi: 10.4269/ajtmh.14-0246. Epub 2014 Nov 10.

33.

George J. Armelagos (1936-2014).

Martin DL, Zuckerman MK, Harper KN.

Am J Phys Anthropol. 2014 Dec;155(4):493-5. doi: 10.1002/ajpa.22615. Epub 2014 Sep 19. No abstract available.

PMID:
25242629
34.

Trypanosoma cruzi survival following cold storage: possible implications for tissue banking.

Martin DL, Goodhew B, Czaicki N, Foster K, Rajbhandary S, Hunter S, Brubaker SA.

PLoS One. 2014 Apr 23;9(4):e95398. doi: 10.1371/journal.pone.0095398. eCollection 2014. Erratum in: PLoS One. 2014;9(12):e114783.

35.

Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration.

Goodhew EB, Morgan SM, Switzer AJ, Munoz B, Dize L, Gaydos C, Mkocha H, West SK, Wiegand RE, Lammie PJ, Martin DL.

BMC Infect Dis. 2014 Apr 22;14:216. doi: 10.1186/1471-2334-14-216.

36.

Regional variation in the correlation of antibody and T-cell responses to Trypanosoma cruzi.

Martin DL, Marks M, Galdos-Cardenas G, Gilman RH, Goodhew B, Ferrufino L, Halperin A, Sanchez G, Verastegui M, Escalante P, Naquira C, Levy MZ, Bern C.

Am J Trop Med Hyg. 2014 Jun;90(6):1074-81. doi: 10.4269/ajtmh.13-0391. Epub 2014 Apr 7.

37.

Development and characterization of genomic SSR markers in Cynodon transvaalensis Burtt-Davy.

Tan C, Wu Y, Taliaferro CM, Bell GE, Martin DL, Smith MW.

Mol Genet Genomics. 2014 Aug;289(4):523-31. doi: 10.1007/s00438-014-0829-1. Epub 2014 Mar 2.

PMID:
24585252
38.

Opportunities to investigate the effects of ivermectin mass drug administration on scabies.

Engelman D, Martin DL, Hay RJ, Chosidow O, McCarthy JS, Fuller LC, Steer AC.

Parasit Vectors. 2013 Apr 17;6:106. doi: 10.1186/1756-3305-6-106.

39.

CT694 and pgp3 as serological tools for monitoring trachoma programs.

Goodhew EB, Priest JW, Moss DM, Zhong G, Munoz B, Mkocha H, Martin DL, West SK, Gaydos C, Lammie PJ.

PLoS Negl Trop Dis. 2012;6(11):e1873. doi: 10.1371/journal.pntd.0001873. Epub 2012 Nov 1.

40.

Indigenous violence in Northern Mexico on the eve of contact.

Anderson CP, Martin DL, Thompson JL.

Int J Paleopathol. 2012 Jun - Sep;2(2-3):93-101. doi: 10.1016/j.ijpp.2012.09.017. Epub 2012 Nov 7.

PMID:
29539386
41.

Body parts and parts of bodies: Traces of violence in past cultures.

Martin DL, Harrod RP.

Int J Paleopathol. 2012 Jun - Sep;2(2-3):49-52. doi: 10.1016/j.ijpp.2012.09.016. Epub 2012 Nov 11. No abstract available.

PMID:
29539381
42.

Battered and abused: Analysis of trauma at Grasshopper Pueblo (AD 1275-1400).

Baustian KM, Harrod RP, Osterholtz AJ, Martin DL.

Int J Paleopathol. 2012 Jun - Sep;2(2-3):102-111. doi: 10.1016/j.ijpp.2012.09.006. Epub 2012 Nov 11.

PMID:
29539375
43.

Gradually Guiding Nursing Students through Their Capstone Course: Registered Nurse Preceptors Share Their Experiences.

Martin DL, Brewer MK, Barr N.

Nurs Res Pract. 2011;2011:645125. doi: 10.1155/2011/645125. Epub 2011 Apr 14.

44.

Acute and congenital Chagas disease.

Bern C, Martin DL, Gilman RH.

Adv Parasitol. 2011;75:19-47. doi: 10.1016/B978-0-12-385863-4.00002-2.

PMID:
21820550
45.

A quantitative real-time polymerase chain reaction assay for the seagrass pathogen Labyrinthula zosterae.

Bergmann N, Fricke B, Schmidt MC, Tams V, Beining K, Schwitte H, Boettcher AA, Martin DL, Bockelmann AC, Reusch TB, Rauch G.

Mol Ecol Resour. 2011 Nov;11(6):1076-81. doi: 10.1111/j.1755-0998.2011.03051.x. Epub 2011 Jul 20.

PMID:
21777400
46.

Classification of cardiac arrhythmias using competitive networks.

Leite CR, Martin DL, Sizilio GR, Dos Santos KE, de Araujo BG, Valentim RA, Neto AD, de Melo JD, Guerreiro AM.

Conf Proc IEEE Eng Med Biol Soc. 2010;2010:1386-9. doi: 10.1109/IEMBS.2010.5626728.

PMID:
21096338
47.

Modeling of medical care with stochastic Petri Nets.

Leite CR, Martin DL, Sizilio GR, Dos Santos KE, de Araujo BG, Valentim RA, Neto AD, de Melo JD, Guerreiro AM.

Conf Proc IEEE Eng Med Biol Soc. 2010;2010:1336-9. doi: 10.1109/IEMBS.2010.5626755.

PMID:
21096326
48.

CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.

Rosenberg CS, Martin DL, Tarleton RL.

J Immunol. 2010 Jul 1;185(1):560-8. doi: 10.4049/jimmunol.1000432. Epub 2010 Jun 7.

49.

Generation of Trypanosoma cruzi-specific CD8+ T-cell immunity is unaffected by the absence of type I interferon signaling.

Martin DL, Murali-Krishna K, Tarleton RL.

Infect Immun. 2010 Jul;78(7):3154-9. doi: 10.1128/IAI.00275-10. Epub 2010 May 10.

50.

Liquid culture and growth quantification of the seagrass pathogen, Labyrinthula spp.

Martin DL, Boone E, Caldwell MM, Major KM, Boettcher AA.

Mycologia. 2009 Sep-Oct;101(5):632-5.

PMID:
19750942

Supplemental Content

Loading ...
Support Center